Related Experiment Video
Updated: Jul 18, 2026

Protein Misfolding Cyclic Amplification of Prions
Published on: November 7, 2012
Allelic origin of the abnormal prion protein isoform in familial prion diseases
1Division of Neuropathology, Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Abstract:
The hallmark of prion diseases is the presence of an aberrant isoform of the prion protein (PrP(res)) that is insoluble in nondenaturing detergents and resistant to proteases. We investigated the allelic origin of PrP(res) in brains of subjects heterozygous for the D178N mutation linked to fatal familial insomnia (FFI) and a subtype of Creutzfeldt-Jakob disease (CJD178), as well as for insertional mutations associated with another CJD subtype. We found that in FFI and CJD178 subjects, only mutant PrP was detergent-insoluble and protease-resistant. Therefore, PrP(res) derives exclusively from the mutant allele carrying the D178N mutation. In contrast, in the CJD subtype harboring insertional mutations, wild-type PrP was also detergent-insoluble and likely to be protease-resistant. Our findings indicate that the participation of the wild-type PrP in the formation of PrP(res) depends on the type of mutations, providing an insight into the molecular mechanisms underlying the phenotypic heterogeneity in familial prion diseases.
Insights
Prion diseases involve abnormal prion protein (PrP). This study shows mutant PrP causes PrP(res) in fatal familial insomnia and CJD178, while insertional mutations can involve wild-type PrP, explaining disease diversity.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Prion diseases are characterized by abnormal prion protein (PrP(res)), which is detergent-insoluble and protease-resistant.
- Understanding the source of PrP(res) is crucial for elucidating disease mechanisms and heterogeneity.
Purpose of the Study:
- To investigate the allelic origin of PrP(res) in individuals with specific prion protein gene mutations.
- To determine whether wild-type or mutant prion protein contributes to PrP(res) formation in different familial prion disease subtypes.
Main Methods:
- Analysis of brain tissue from subjects heterozygous for D178N mutation (linked to FFI and CJD178) and insertional mutations.
- Assessing detergent insolubility and protease resistance of prion protein isoforms.
Main Results:
- In FFI and CJD178, only mutant prion protein (PrP) was detergent-insoluble and protease-resistant, indicating PrP(res) exclusively from the mutant allele.
- In contrast, a CJD subtype with insertional mutations showed both wild-type and mutant PrP becoming detergent-insoluble and protease-resistant.
Conclusions:
- The allelic origin of PrP(res) formation is mutation-dependent.
- Wild-type prion protein can participate in PrP(res) formation in certain familial prion diseases, contributing to phenotypic variability.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
RNA Splicing
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

